SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 144 - Report of proposed sale of securities:
SEC Accession No. 0000950170-24-082854
Filing Date
2024-07-11
Accepted
2024-07-11 07:35:02
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3277
  Complete submission text file 0000950170-24-082854.txt   4966
Mailing Address C/O CANDEL THERAPEUTICS, INC. 117 KENDRICK ST SUITE 450 NEEDHAM MA 02494
Business Address
Nichols William Garrett (Reporting) CIK: 0001618364 (see all company filings)

Type: 144

Mailing Address 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494
Business Address 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494 617-916-5445
Candel Therapeutics, Inc. (Subject) CIK: 0001841387 (see all company filings)

IRS No.: 522214851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-40629 | Film No.: 241111036
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)